www.lilly.com Open in urlscan Pro
54.161.241.46  Public Scan

Submitted URL: http://www.lillyventures.com/
Effective URL: https://www.lilly.com/partners
Submission: On October 08 via api from US — Scanned from DE

Form analysis 0 forms found in the DOM

Text Content

Accessibility Statement
Skip to main content


This website uses cookies and other technologies to personalize content and ads
on this and other websites and provide social media features. By clicking "I
Agree" you consent to our use of tracking technologies and disclosure of
tracking data to third party ad networks or social media companies for the
purposes above. If you click "I Disagree" you can still use this website. For
more information about Lilly's privacy practice and to manage third-party
preferences, click here.

I Disagree I Agree
   
 * ESG Report
 * Careers
 * Partners
 * Investors
 * Contact
 * Globe

Lilly
Menu Menu
Menu closed
Lilly
Close Close
   
 * Company
   Expand mega menu
   Expand submenu
   Left Back
   Company
   WHO WE ARE
   Expand
      
    * About Lilly
    * Key Facts
    * Recognitions
    * Powered by Purpose
   
   LEADERSHIP
   Expand
      
    * Governance
    * Executive Committee
    * Board of Directors
   
   POLICIES & REPORTS
   Expand
      
    * Public Policy
    * Annual Report & Proxy Statement

 * Science
   Expand mega menu
   Expand submenu
   Left Back
   Science
   DISCOVERY
   Expand
      
    * Clinical Development Pipeline
    * Research & Scientific Discovery
    * Principles of Medical Research
    * The Elixir Factor Podcast
    * 100 Years of Insulin
   
   DISEASE AREAS
   Expand
      
    * Alzheimer's
    * Cancer
    * Diabetes
    * Immunology
    * Obesity
    * Pain
   
   CLINICAL RESEARCH
   Expand
      
    * Clinical Trials
    * Diversity in Clinical Trials
    * Lilly Trials
    * Expanded Access
    * CSR Synopses
   
   PARTNERS
   Expand
      
    * Collaborate With Us
    * Scientific Areas of Interest
    * Our Approach to Partnering
    * Office of Alliance Management
    * Lilly Research Award Program

 * Medicines
   Expand mega menu
   Expand submenu
   Left Back
   Medicines
   SAFETY
   Expand
      
    * Patient Safety
    * Medication Safety
    * Manufacturing & Quality
   
   OUR MEDICINES
   Expand
      
    * Current Medicines
    * Historic Medicines
    * Suggestions for Patients
   
   RESOURCES
   Expand
      
    * Lilly Diabetes Solution Center
    * Lilly Insulin State Patient Assistance Programs
    * Lilly Oncology Support Center
    * Lilly Pricing Information
    * The Lilly Answers Center
    * Lilly Cares Foundation

 * Impact
   Expand mega menu
   Expand submenu
   Left Back
   Impact
   OUR IMPACT
   Expand
      
    * Overview
    * Lilly Foundation
    * Lilly Grant Office
   
   IMPACT AREAS
   Expand
      
    * Increase Access to Medicines
    * Improve Lives and Communities
    * Empower a Diverse Workforce
    * Minimize Our Environmental Impact
    * Operate Ethically and Responsibly
   
   TRANSPARENCY
   Expand
      
    * ESG Report
    * State-Specific Requirements

 * News
   Expand mega menu
   Expand submenu
   Left Back
   News
   STORIES
   Expand
      
    * Caring
    * Science
    * Policy
    * All Stories
   
   PRESS RELEASES
   Expand
      
    * Recent
    * Archives
   
   MEDIA
   Expand
      
    * All News
    * Media Kits
    * Media Contacts
    * Social Media Guidelines
    * 

 * Search

   
 * ESG Report
 * Careers
 * Partners
 * Investors
 * Contact
 * Globe


SMART RISKS. BOLD SCIENCE.

At Lilly, we take smart risks on bold science to bring life-changing medicines
to patients.

Let's Collaborate


OUR APPROACH TO PARTNERING



Learn More


SCIENTIFIC AREAS OF INTEREST



Learn More

> Quotes
> 
> 
> AS A COMMUNITY OF SCIENTISTS, WE APPRECIATE THE BRILLIANCE AND DEDICATION
> REQUIRED TO UNCOVER THE NEXT POTENTIAL MEDICAL BREAKTHROUGHS. WE TAKE
> SERIOUSLY OUR RESPONSIBILITY AS PARTNERS IN STEWARDING YOUR IDEA TO SUCCESS.
> 
> Kenneth Custer, Ph.D.Head of Business Development


180+



Actively managed alliances


15/20



of Lilly’s last new launches enabled by external innovation 


2B+



committed to biotech over the last 20 years through venture investing 


FIND LILLY AT UPCOMING EVENTS

See where we will be next, and request a meeting.

Partnering Events


LILLY IN THE NEWS

Lilly and Entos Pharmaceuticals Enter into Research and Collaboration Agreement
to Support the Development of Innovative Therapies in Multiple Neurologic
Indications

January 6, 2022

--------------------------------------------------------------------------------

Lilly and Foghorn Announce Strategic Collaboration for Novel Oncology Targets
Using Foghorn's Proprietary Gene Traffic Control® Platform

December 13, 2021

--------------------------------------------------------------------------------

Lilly and Regor Therapeutics Group Enter into Strategic Collaboration to
Discover and Develop Novel Therapies for Metabolic Disorders

December 10, 2021

--------------------------------------------------------------------------------

Lilly and Lycia Therapeutics Enter into Strategic Collaboration to Discover and
Develop Novel Lysosomal Targeting Chimera (LYTAC) Degraders

August 25, 2021

--------------------------------------------------------------------------------

Lilly and Kumquat Biosciences Announce Collaboration to Discover and Develop
Novel Small Molecules that Stimulate Tumor-Specific Immune Responses

July 29, 2021

--------------------------------------------------------------------------------




MEET OUR OFFICE OF ALLIANCE MANAGEMENT



Learn More


GET IN TOUCH

Tell us about your biotech innovation.

Start the Conversation

Diversity
Contact
Suppliers
Login
Terms of Use
Privacy Statement
Accessibility Statement
Sitemap

To speak to customer support:
Call (800) 545-5979

This site is intended for U.S. residents ages 18 and older.
Copyright © 2022 Lilly. All rights reserved.
Twitter Facebook Instagram LinkedIn YouTube
Terms of Use Privacy Statement Accessibility Statement Sitemap
Lilly